Tenax Therapeutics
(TENX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 04-2015 | 04-2014 | 04-2013 | 04-2012 | 04-2011 | |
| Sales | 49 | 289 | 1,234 | 415 | 322 |
| Cost of Goods | N/A | 130 | 43 | 51 | 219 |
| Gross Profit | 49 | 159 | 1,191 | 364 | 103 |
| Operating Expenses | 14,866 | 16,900 | 6,423 | 8,635 | 10,885 |
| Operating Income | -14,817 | -16,611 | -5,189 | -8,220 | -10,563 |
| Interest Expense | 49 | 2,212 | 4,239 | 7,412 | 172 |
| Other Income | 784 | -718 | 12 | -80 | 286 |
| Pre-tax Income | -14,082 | -19,542 | -9,416 | -15,712 | -10,448 |
| Net Income Continuous | -14,082 | -19,542 | -9,416 | -15,712 | -10,448 |
| Net Income | $-14,082 | $-19,542 | $-9,416 | $-15,712 | $-10,448 |
| EPS Basic Total Ops | -16,000.00 | -86,720.00 | -201,280.00 | -387,840.00 | -0.45 |
| EPS Basic Continuous Ops | -16,048.79 | -66,795.42 | -182,609.50 | -387,960.70 | -0.45 |
| EPS Diluted Total Ops | -16,000.00 | -86,720.00 | -213,760.00 | -450,240.00 | -0.45 |
| EPS Diluted Continuous Ops | -16,048.79 | -66,795.42 | -171,293.70 | -362,245.80 | -0.45 |
| EBITDA(a) | $-13,994 | $-16,461 | $-5,040 | $-8,014 | $-10,252 |